Stockhead on MSN6h
Health Check: Mayne Defenders fight ‘inadequate’ takeover offerA small group of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not capture the upside of ... Read ...
The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...
A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...
SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call A replay of the call will be available after 7:30 pm ET and can be accessed as follows: The webcast replay is ...
Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Shares of Tonix Pharmaceuticals are pulling back 12.7% during Thursday's session. The stock is pulling back following a regulatory update on its experimental fibromyalgia treatment, TNX-102 SL.
A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...
The FDA launches sweeping changes to food safety rules that could transform grocery aisles nationwide as untested ingredients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback